NDC11 00469052002
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00469-0520-02 | 00469-0520 |
| 00469-0520-2 | 00469-0520 |
| 00469-520-02 | 00469-520 |
| 0469-0520-02 | 0469-0520 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CRESEMBA | ISAVUCONAZONIUM SULFATE | Astellas Pharma US, Inc. | 8f7f73b8-586a-4df0-935f-fecd4696c16c | 2025-04-25 | Warnings, Adverse reactions | 0469-0520-02 0469-0520 00469052002 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.